June 2025
Moneycontrol: Latha & The Leaders: Kiran Mazumdar Shaw On GLP-1 Drugs That Targets Diabetes And Obesity
Moneycontrol: Biocon in a position to be dominant player in diabetes-obesity space: Kiran Mazumdar Shaw
Prameya News: Biocon Targets ‘Diabesity’: Biocon’s Kiran Mazumdar Shaw Sees Massive Opportunity in GLP-1 Drugs for Diabetes and Obesity
May 2025
Forbes: Meet India’s Self-Made Biologics Brewmaster Billionaire
Financial Express: ‘Did India miss its orange economy opportunity with Sholay?’: Kiran Mazumdar-Shaw
CNBC-TV18: Kiran Mazumdar-Shaw urges industry to use tech and films in helping build creative economy
Press Information Bureau (PIB): Kiran Mazumdar Shaw charts India’s creative future at WAVES, says startups should think beyond films and build brands that create global waves
United News of India (UNI): Biocon to invest in Maharashtra, we will support: CM Fadnavis
Free Press Journal: Exclusive: Entrepreneur Kiran Mazumdar-Shaw Highlights What Happens When Branding Meets AI